Bruker Corporation

Laboratory Analytical Instruments

BRKRStrained7 of 11 basics passed

$58.84

+1.59%

Market cap $8.96B

$58.84

+1.59%

Market cap $8.96B

Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries.

It is a $8.96B technology company. Revenue grew 1.6% over the last year, it currently loses money, and its net debt equals ~16.7 years of free cash flow.

Website: bruker.com
Location: Billerica, MA
Employees: 11 085
Sector: Technology
Founded: 1960

Share price · 3 years

$64.17 → $58.84-8.3%

price only — dividends excluded

Key facts · TTM

Revenue: total sales; $3.50B
Loss: spends more than it earns; -$71.2M
Free cash flow: cash left after running the business; $93.9M
Net debt: debt minus cash on hand; $1.57B
P/E: years of profit in the price; 33.1
Dividend: pays out 91% of profit · 58% of FCF; 0.61%
Shares: down 6% since 2016 — buybacks; 151.8M
Volatility: beta vs the market — under 1 swings less; 1.23

Revenue, last 10 years

52-week range

Low $32.76$58.84High $64.75

Today's price is 82% of the way from the year's low to its high.

Valuation vs own history

P/E

58.9×

11%

P/S

2.6×

70%

EV/EBITDA

33.9×

28%

P/B

3.7×

73%

FCF yield

1.0%

14%

Share of the last ~5 years that was pricier than today (pricier than usual). Based on the daily valuation record.

Insider activity · 90 days

-$303Knet selling

Purchases$0

Sales$303K

Insiders trading, last 14d0 buy · 0 sell

Standing in Technology

Size$8.96Btop 91%
Revenue growth+11%top 50%
Net margin-2%top 86%
Return on equity-3%top 88%
P/E33.1×top 46%
Dividend yield0.61%top 62%

Ranked against 220 Technology companies with a full CV — for P/E, lower ranks higher.

Skills

Six independent scores, 0–100, built from reported numbers and valuation history. Click a row to see how it was scored.

Valuation, Growth, Profitability and Health lag behind.

Valuation25

P/E vs own history89th pct · 0/25
FCF yield1.0% · 5/25
P/S2.6x · 20/25
EV/EBITDA60.0x · 0/25

Growth32

Revenue CAGR9.2% · 12/25
Net income CAGRn/a · 0/25
EPS CAGR ~5Yn/a · 0/25
Fwd implied growth26.1% · 20/25

Profitability0

ROIC-0.2% · 0/25
ROE-2.9% · 0/25
Net margin-2.0% · 0/25
Operating margin-1.5% · 0/25

Health33

Altman Zn/a · 0/25
Current ratio1.85 · 18/25
Interest coverage1.8x · 3/25
Net cash / debtD/A 25% · 12/25

Quality50

Piotroski F4/9 · 10/25
Beneish M-2.44 · 20/25
FCF conversionn/a · 0/25
Margin stabilityσ 5.2% · 20/25

Moat70

ROIC >12% years8/10 yrs · 20/25
Median gross margin47.8% · 20/25
FCF-positive years10/10 yrs · 25/25
Worst-year net marginworst -0.3% · 5/25

How the scores work →

Experience

The company's career so far — founding, the IPO, landmark products and acquisitions, plus revenue milestones and insider buying.

FY2023Financial
Best year on record
$427M net income
2022Acquisition
It was announced Bruker had acquired the Mountain View-headquartered miniaturized microscope /…
2020Acquisition
Bruker acquired Canopy Biosciences
2019Acquisition
Bruker bought Alicona, known for production of metrology equipment based on focus variation, to extend its…
FY2016Financial
First recorded profitable year
$154M net income
FY2016Financial
Revenue already above $1B
$1.61B in first reported year
FY2016Financial
Positive free cash flow every year since
10-year streak
2012Acquisition
They have since divested these products to Scion Instruments with the exception of the triple quadrupole In 2012,…
2010Product
Bruker created a Chemical Analysis Division (headquartered in Fremont, CA) under the Bruker Daltonics…
2010Acquisition
Bruker bought 3 product lines from Agilent, which Agilent had acquired from Varian
2001Acquisition
This division contains three former Varian product lines: ICPMS systems, laboratory gas chromatography (GC)
1997Acquisition
The analytical X-ray division of Siemens was acquired by Bruker
1969Product
Bruker launched the first commercial Fourier transform NMR spectroscopy system (FT-NMR) and in the 1970s…
Sep 7, 1960Founded
The company was founded on September 7, 1960, in Karlsruhe, Germany as Bruker-Physik AG by five people, one of them…

Achievements

Verifiable track record, straight from the reported numbers.

$10 000 invested in 2021 would be worth ~$7 053 today — price return only

$3.4B revenue in FY2025

Positive free cash flow 10 years in a row

11 085 employees

Strengths & watch-outs

What a bull and a bear would each point to. Both lists come from the reported numbers, not opinions.

Strengths

High gross margin (47.7%)

Watch-outs

Not profitable — 2.0% net margin
Thin interest coverage (1.8×)
Loss-making in 1 of the recent years
Net debt equals ~16.7 years of free cash flow

Qualifications

The basics a company should meet before you research it further. Each check uses the reported numbers.

7 of 11 checks passed

Revenue growing — the company sells more than a year ago+1.6% YoY
Profitable — makes more than it spends-$71.2M TTM
Profit growing — earnings are higher than last year-107.6% YoY
Generates cash — cash left after running and investing$93.9M TTM
Debt under control — could handle its obligations~16.7y of cash flow to repay
Established company — not a micro-cap — lower blow-up risk$8.96B market cap
Not printing shares — share count not ballooning — you keep your slice-1.8% shares over ~5y
Proven track record — years of profitability behind it9/10 profitable years
Financially stable — balance sheet not near distresshealth score 21/100
Pays a dividend — returns cash to shareholdersyield 0.61%
Valuation not extreme — price not wildly above earningsP/E 33.1

Peer comparisonBruker Corporation vs 6 largest technology peers — cap, P/E, growth and margin side by sideOpen ▾

Company	Market cap	P/E	Revenue growth	Net margin	Profile
BRKR this company	$9.0B	33.1	+1.6%	-2.0%	Strained
NVDA Nvidia Corp	$5.5T	28.6	+83.4%	63.7%	Mixed
AAPL Apple Inc.	$4.9T	38.1	+14.2%	27.6%	Strong
GOOGL Alphabet Inc.	$4.3T	17.6	+20.1%	54.8%	Mixed
MSFT Microsoft Corp	$4.0T	29.7	+17.8%	40.3%	Strong
SPCX Space Exploration Technologies Corp.	$2.1T	—	+33.2%	-34.0%	Strained
META Meta Platforms, Inc.	$1.8T	26.9	+27.7%	29.8%	Mixed

Head-to-head: BRKR vs NVDA · BRKR vs AAPL · BRKR vs GOOGL

References

What covering analysts publish about the company — information only, not a recommendation.

Strong buy 6Buy 7Hold 7Sell 1

Appendix · Financial records

The full statements behind this CV, FY2016–FY2025. For readers who want to check the numbers.

Profit & lossRevenue $3.50B · net income -$71.2M (TTM)Open ▾

Profit & loss

Revenue and profit over the company's career — the income statement, visualised.

How FY2025 revenue flows to profit

RevenueNet income

Revenue (TTM)

$3.50B

YoY 1.6%

Net income (TTM)

-$71.2M

Margin -2.0%

Gross margin

47.7%

Operating margin

-1.5%

P/E ratio

33.1

Dividend yield

0.61%

Income statement — full detail

Figures in USD billions · EPS in USD

	2020	2021	2022	2023	2024	2025
Revenue	2.0	2.4	2.5	3.0	3.4	3.4
Gross profit	0.9	1.2	1.3	1.5	1.6	1.6
Operating income (EBIT)	0.2	0.4	0.4	0.5	0.3	0.1
Net income	0.2	0.3	0.3	0.4	0.1	-0.0
EPS (diluted)	1.02	1.81	1.99	2.94	0.76	-0.06

Cash flowFree cash flow $93.9M · operating cash flow $190M (TTM)Open ▾

Cash flow statement

Cash generated by the business and what is left after investment — year by year.

Operating cash flowFree cash flow

Free cash flow (TTM)

$93.9M

Margin 2.7%

Operating cash flow (TTM)

$190M

FCF margin

2.7%

Cash flow statement — full detail

Figures in USD billions

	2020	2021	2022	2023	2024	2025
Operating cash flow	0.3	0.3	0.3	0.4	0.3	0.1
Capital expenditure	-0.1	-0.1	-0.1	-0.1	-0.1	-0.1
Free cash flow	0.2	0.2	0.1	0.2	0.1	0.0
FCF margin	11.8%	7.9%	5.7%	8.2%	4.0%	1.3%

Balance sheetAssets $6.24B · net debt $1.57B (FY2025)Open ▾

Balance sheet

How the balance sheet is built — what it owns versus how it is financed.

How $6.24B of assets is financed

60%

40%

Liabilities $3.73B — borrowed moneyEquity $2.46B — owners' stake

Cash vs debt

Total debt $1.87B − cash $299M = net debt $1.57B

Cash on hand covers 16% of debt.

Debt repayment

0.0 yrs

Years of free cash flow to clear net debt

Interest coverage

1.8x

EBIT ÷ interest expense

ROE

-2.9%

Profit per $1 of equity

Balance sheet — full detail

Figures in USD billions

	2020	2021	2022	2023	2024	2025
Cash & equivalents	0.7	1.2	0.6	0.5	0.2	0.3
Total assets	3.0	3.6	3.6	4.2	5.8	6.2
Total liabilities	2.1	2.6	2.5	2.8	4.0	3.7
Total debt	0.8	1.3	1.2	1.4	2.1	1.9
Equity	1.0	1.1	1.1	1.4	1.8	2.5
Net debt	0.1	0.2	0.6	0.9	1.9	1.6

Want the live picture — intraday moves, valuation history and full analysis?

Deeper analysis of BRKR on PreMarketPrice

Figures are derived from company filings (quarterly values normalised from as-filed year-to-date data where applicable) and may be delayed, restated or incomplete. This page is information, not investment advice. Latest price $58.84 · market cap $8.96B.